Maximus (MMS)
(Delayed Data from NYSE)
$90.10 USD
+1.55 (1.75%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $90.08 -0.02 (-0.02%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$90.10 USD
+1.55 (1.75%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $90.08 -0.02 (-0.02%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth F Momentum B VGM
Zacks News
MAXIMUS (MMS) Q2 Earnings Top, Stock Down 8.8% on Tepid EPS View
by Zacks Equity Research
MAXIMUS (MMS) second-quarter fiscal 2022 earnings fall, while revenues rise year over year.
Maximus (MMS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 9.18% and 8.58%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Reasons to Add Maximus (MMS) Stock to Your Portfolio Now
by Zacks Equity Research
With more than 40 years of experience, Maximus has grown to be a leading operator of government health and human services programs globally.
Wall Street Analysts See a 31% Upside in Maximus (MMS): Can the Stock Really Move This High?
by Zacks Equity Research
The consensus price target hints at a 31.3% upside potential for Maximus (MMS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Maximus (MMS) Up on Strategic Acquisitions Amid High Debt
by Zacks Equity Research
Maximus' (MMS) expertise in business process management, and its ability to deliver cost-effective, efficient and high-scale solutions, position it as a lucrative partner to governments.
Wall Street Analysts See a 33% Upside in Maximus (MMS): Can the Stock Really Move This High?
by Zacks Equity Research
The consensus price target hints at a 33.3% upside potential for Maximus (MMS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
MAXIMUS (MMS) Beats on Q1 Earnings, Raises '22 Revenue View
by Zacks Equity Research
MAXIMUS's (MMS) first-quarter 2022 earnings and revenues improve year over year.
Maximus (MMS) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 40% and 5%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Maximus (MMS) Q1 Earnings Expected to Decline
by Zacks Equity Research
Maximus (MMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Investors Should Retain Maximus (MMS) Stock Now
by Zacks Equity Research
Strategic acquisitions and investor-friendly measures boost Maximus (MMS) stock. However, high debt is a headwind.
Investor-Friendly Steps Aid MAXIMUS (MMS), High Debt Ails
by Zacks Equity Research
MAXIMUS (MMS) rides on solid shareholder-friendly measures and strategic acquisitions. However, a high debt balance is a concern.
MAXIMUS (MMS) Q4 Earnings Surpass Estimates, Increase Y/Y
by Zacks Equity Research
New COVID-19 response work drives MAXIMUS (MMS) Q4 fiscal 2021 performance.
Maximus (MMS) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 21.35% and 2.11%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Is Maximus (MMS) a Suitable Stock for Value Investors Now?
by Vedika Agarwal
Let's see if Maximus (MMS) stock is a good choice for value-oriented investors right now from multiple angles.
Navient (NAVI) to Exit From Federal Student Loan Servicing
by Zacks Equity Research
Navient (NAVI) will transfer the accounts of nearly six million federal student loan borrowers to Maximus, thereby ceasing the loan payment collections on behalf of the U.S. Department of Education.
Here's Why You Should Retain MAXIMUS (MMS) Stock for Now
by Zacks Equity Research
Shareholder-friendly measures and strategic acquisitions drive MAXIMUS (MMS). However, high debt is a headwind.
Shareholder-Friendly Steps Aid MAXIMUS (MMS), High Debt Ails
by Zacks Equity Research
Solid track record of dividend payments is encouraging for MAXIMUS (MMS). However, debt-laden balance sheet is a concern.
MAXIMUS (MMS) Stock Drops 3.7% In Spite of Q3 Earnings Beat
by Zacks Equity Research
New COVID-19 response work aids MAXIMUS (MMS) Q3 fiscal 2021 performance.
Maximus (MMS) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 48.21% and 13.31%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Maximus (MMS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Maximus (MMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Hold MAXIMUS (MMS) in Your Portfolio
by Zacks Equity Research
MAXIMUS's (MMS) business process management expertise and ability to deliver cost-effective, efficient and high-scale solutions make it a lucrative partner to governments.
Strategic Acquisitions Aid MAXIMUS (MMS), High Debt Ails
by Zacks Equity Research
Strategic acquisitions complement MAXIMUS' (MMS) long-term organic growth strategy. However, high debt is a concern.
MAXIMUS (MMS) Falls 3.9% Despite Beating on Q2 Earnings
by Zacks Equity Research
New COVID-19 response work and increase in operating income drives MAXIMUS (MMS) second-quarter fiscal 2021 finacials.
Maximus (MMS) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 57.32% and 15.68%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Maximus (MMS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Maximus (MMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.